Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06986538

Extent of Lymph Node Dissection for Advanced Right-Sided Colon Cance

This is a prospective multicenter randomized controlled clinical study to explore the extent of lymph node dissection in progressive right hemicolon cancer and to elucidate the pattern of lymphatic drainage in the right hemicolon.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cancer Hospital, Chinese Academyof Medical Sciences, Beijing, Beijing Municipality, China

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: 18-75 years
  • Preoperative pathologic confirmation of adenocarcinoma
  • Tumor located in the region from the ileocecal valve to the right one-third of the transverse colon
  • American Society of Anesthesiologists (ASA) physical status classification I to III
  • Patients who have not received preoperative radiotherapy, chemotherapy, or immunotherapy
  • Preoperative imaging staging cT4N0M0 or cT3-4N+M0
  • Willing to participate in the study and sign the informed consent form

Exclusion criteria

  • Past medical history of malignant tumor
  • Patients with multiple primary tumors
  • Patients with a history of inflammatory bowel disease or familial adenomatous polyposis
  • Patients with distant metastasis
  • Pregnant or breastfeeding women
  • History of other previous major abdominal surgery
  • Patients requiring emergency surgery (including tumor perforation, obstruction, hemorrhage, etc.)
  • Those with other clinical and laboratory conditions deemed by the investigator to be inappropriate for participation in the trial

Treatment and study plan

Clearance with the left side of the SMV as the medial boundary

Procedure

Undergo radical resection for right colon cancer with the left side of the SMV as the medial boundary

Clearance with the left side of the SMA as the medial boundary

Procedure

Undergo radical resection for right colon cancer with the left side of the SMA as the medial boundary

Primary outcomes

  1. Disease-Free Survival

    Time frame: The third postoperative year

    It is defined as the proportion of patients from the start of randomization to the end of the third year without any of the following events: disease progression, local recurrence, distant metastasis, second primary colorectal cancer, or death from any cause.

Secondary outcomes

  1. overall survival

    Time frame: The third postoperative year

    The time from randomization to death from any cause.

Study contacts

Contact information is provided by the study sponsor or research team.

Dechang Diao

CONTACT

[email protected]

+8619120517547

Jiaqi Ren

CONTACT

[email protected]

+8619120517547

Sponsors and collaborators

Lead sponsor

Sixth Affiliated Hospital, Sun Yat-sen University

Other

Registry information

Official study title

A Multicenter Randomized Controlled Study of the Extent of Lymph Node Dissection for Advanced Right-sided Colon Cancer

Acronym: MARCH

Important dates

Study start
2025
Primary completion
2029
Study completion
2029
First posted
May 23, 2025
Registry last updated
May 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.